The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

H. David Humes

Department of Internal Medicine

University of Michigan and VA Medical Center

Ann Arbor 48109-0368

USA

[email]@umich.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Internal Medicine, University of Michigan and VA Medical Center, Ann Arbor 48109-0368, USA. 1997 - 2006
  • Research and Development Division, Nephros Therapeutics Inc. and Department of Internal Medicine, University of Michigan Medical School, 1150 W. Medical Center Drive, USA. 2004

References

  1. The future of hemodialysis membranes. Humes, H.D., Fissell, W.H., Tiranathanagul, K. Kidney Int. (2006) [Pubmed]
  2. Stem cells: the next therapeutic frontier. Humes, H.D. Trans. Am. Clin. Climatol. Assoc. (2005) [Pubmed]
  3. Renal cell therapy in the treatment of patients with acute and chronic renal failure. Humes, H.D., Weitzel, W.F., Fissell, W.H. Blood Purif. (2004) [Pubmed]
  4. Advances in cell therapy for renal failure. Humes, H.D., Szczypka, M.S. Transpl. Immunol. (2004) [Pubmed]
  5. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Humes, H.D., Weitzel, W.F., Bartlett, R.H., Swaniker, F.C., Paganini, E.P., Luderer, J.R., Sobota, J. Kidney Int. (2004) [Pubmed]
  6. Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure. Humes, H.D., Weitzel, W.F., Bartlett, R.H., Swaniker, F.C., Paganini, E.P. Blood Purif. (2003) [Pubmed]
  7. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Humes, H.D., Buffington, D.A., Lou, L., Abrishami, S., Wang, M., Xia, J., Fissell, W.H. Crit. Care Med. (2003) [Pubmed]
  8. Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Humes, H.D., Fissell, W.H., Weitzel, W.F., Buffington, D.A., Westover, A.J., MacKay, S.M., Gutierrez, J.M. Am. J. Kidney Dis. (2002) [Pubmed]
  9. The bioartificial kidney in the treatment of acute renal failure. Humes, H.D., Fissell, W.H., Weitzel, W.F. Kidney Int. Suppl. (2002) [Pubmed]
  10. Bioartificial kidney for full renal replacement therapy. Humes, H.D. Semin. Nephrol. (2000) [Pubmed]
  11. Replacement of renal function in uremic animals with a tissue-engineered kidney. Humes, H.D., Buffington, D.A., MacKay, S.M., Funke, A.J., Weitzel, W.F. Nat. Biotechnol. (1999) [Pubmed]
  12. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Humes, H.D., MacKay, S.M., Funke, A.J., Buffington, D.A. Kidney Int. (1999) [Pubmed]
  13. Insights into ototoxicity. Analogies to nephrotoxicity. Humes, H.D. Ann. N. Y. Acad. Sci. (1999) [Pubmed]
  14. The bioartificial renal tubule assist device to enhance CRRT in acute renal failure. Humes, H.D., MacKay, S.M., Funke, A.J., Buffington, D.A. Am. J. Kidney Dis. (1997) [Pubmed]
 
WikiGenes - Universities